Cara Therapeutics | CARA - Debt

Stock Price
3.93
Daily Change
-0.09 -2.24%
Monthly
2.88%
Yearly
-73.37%
Q1 Forecast
3.87

Cara Therapeutics reported $0 in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Acadia Pharmaceuticals USD 54.81M 1.48M Sep/2025
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Assertio Holdings USD 38.87M 615K Sep/2023
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Chugai Pharma JPY 14.11B 1.93B Dec/2022
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Grifols EUR 9.23B 626.05M Dec/2024
Halozyme Therapeutics USD 1.51B 1.66M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Neurocrine Biosciences USD 428.4M 10.7M Sep/2025
Pacira USD 372.19M 4.53M Dec/2025
Pfizer USD 60.85B 78M Sep/2025
RedHill Biopharma USD 214K 142K Jun/2025
Supernus Pharmaceuticals USD 42.21M 10.44M Sep/2025
Vanda Pharmaceuticals USD 4.96M 4.96M Dec/2024